UNSPSC 51162312: Acetaminophen/chlorpheniramine/phenylephrine/salicylamide

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51162312 Acetaminophen/chlorpheniramine/phenylephrine/salicylamide is a Commodity code that captures pharmaceutical products and related healthcare supplies procured by state and local governments. The recent activity under this code shows state correctional facilities and county public health agencies buying parenteral nutrition solutions, intravenous products, naloxone, and drug deactivation systems to support medically necessary care and community health initiatives. The Washington State Department of Corrections and Seminole County, Florida represent the issuing bodies active in this space, spanning both corrections and public health procurement.

The Washington State Department of Corrections posted RFQQK13020 on September 8, 2026 (due October 7, 2026) to solicit parenteral products and services — including TPN, PPN, intravenous solutions, and controlled substances — for eight correctional facilities across three regions (West, Central, and East Washington), with anticipated awards of up to three contractors per region and a contract term of November 26, 2026 through June 30, 2030. The solicitation emphasizes 24-hour turnaround on parenteral nutrition bags and 8-hour delivery on initial supplies, requires documented experience with IV preparation and parenteral nutrition monitoring, and includes set-aside aspirations for small business (25%), minority-owned business (10%), women-owned business (6%), and veteran-owned business (5%). Seminole County, Florida issued IFB60459723LAS in June 2026 for annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries, a two-year initial term with one-year renewal option, and potential FEMA funding.